Lan Quach
Physician Assistant · San Diego, CANPI 1730462904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 415 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 415 payments — averaging $39.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- Axsome Therapeutics, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Lundbeck LLC$1K
- plus $5K from 14 others
What the payments were for
- Consulting fees$1151%
- Food & beverage$16,12099%
- Education$630%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 36 | $2,396 |
| Otsuka America Pharmaceutical, Inc. | 37 | $2,003 |
| AbbVie | 62 | $1,828 |
| Axsome Therapeutics, Inc. | 32 | $1,822 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $1,751 |
| Lundbeck LLC | 69 | $1,451 |
| Alkermes, Inc. | 29 | $1,190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $1,113 |
| Johnson & Johnson | 11 | $835 |
| Teva Pharmaceuticals USA, Inc. | 6 | $514 |
| Vanda Pharmaceuticals Inc. | 10 | $391 |
| Almatica Pharma LLC | 10 | $287 |
| Brainsway USA Inc | 1 | $162 |
| Idorsia Pharmaceuticals US Inc | 6 | $131 |
| Ironshore Pharmaceuticals Inc. | 4 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Avanir Pharmaceuticals, Inc. | 1 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$2,217
- INGREZZA$1,776
- Auvelity$1,308
- CAPLYTA$961
- REXULTI$889
- VRAYLAR$865
- ARISTADA$460
- ABILIFY MAINTENA$351
- SPRAVATO$340
- INVEGA SUSTENNA$282
- Fanapt$248
- Austedo XR$247
- UZEDY$230
- Brainsway Deep TMS$162
- INVEGA TRINZA$150
- ABILIFY ASIMTUFII$124
- COBENFY$121
- ARISTADA INITIO$115
How this compares
$16,297 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 96 | $119,853 |
| Austedo XrDeutetrabenazine | 14 | $111,362 |
| RexultiBrexpiprazole | 11 | $18,096 |
| Lurasidone Hcl | 11 | $13,057 |
| Trazodone Hcl | 43 | $726 |
| Duloxetine Hcl | 43 | $592 |
| Bupropion XlBupropion Hcl | 43 | $391 |
| Quetiapine Fumarate | 36 | $380 |
| Gabapentin | 35 | $331 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $271 |
| Clonazepam | 29 | $172 |
| Aripiprazole | 14 | $134 |
| Lamotrigine | 16 | $122 |
| Fluoxetine Hcl | 13 | $118 |
| Mirtazapine | 25 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $835 | $119,85396 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $514 | $111,36214 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $2,003 | $18,09611 claims |
| Almatica Pharma LLCSertraline Hcl | $287 | $9121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in San Diego
- Jeremy AdlerSan Diego$82K
- Anne DenslowSan Diego$43K
- Kathryn SmileySan Diego$33K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.